SCHEMBL7983288

SCHEMBL7983288

CCOP(=O)(CS(=O)(=O)CC1CCN(C(=O)OC(C)(C)C)CC1)OCC

nearest known ligand 0.43

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.43
PKM P14618 1/20 0.43
GPR119 Q8TDV5 11/20 0.43
HPGD P15428 1/20 0.40
SCN9A Q15858 1/20 0.39
RECQL P46063 1/20 0.39
EPHX1 P07099 1/20 0.39
STS P08842 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27494891 0.84 TP53 (0.33) KDM4E
SCHEMBL23135748 0.83 GPR119 (0.50) KDM4EPKMGPR119HPGDRECQL
SCHEMBL7423554 0.82 KDM4E (0.48) KDM4EPKMGPR119HPGDRECQL
SCHEMBL29190839 0.81 KDM4E (0.47) KDM4EPKMGPR119HPGDRECQL
SCHEMBL1575491 0.79 GPR119 (0.47) KDM4EPKMGPR119HPGDRECQL
SCHEMBL12082 0.79 HPGD (0.55) KDM4EPKMGPR119HPGDRECQL
SCHEMBL24510146 0.78 HPGD (0.48) KDM4EPKMGPR119HPGDRECQL
SCHEMBL13537861 0.78 HPGD (0.44) KDM4EPKMGPR119HPGDRECQL
Ammonia Solution, Strong SCHEMBL7871661 0.77 HPGD (0.54) KDM4EPKMGPR119HPGDRECQL
SCHEMBL8624104 0.77 GPR119 (0.47) KDM4EPKMGPR119HPGDRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235731-B1 REDUCING BLOOD LIPIDS, SUGARS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-05-22 US disclosed
EP-0915888-A1 FUSED IMIDAZOPYRIDINE DERIVATIVES AS ANTIHYPERLIPIDEMIC AGENTS Takeda Chemical Industries, Ltd. (JP) 1999-05-19 EP disclosed
WO-1997040051-A1 FUSED IMIDAZOPYRIDINE DERIVATIVES AS ANTIHYPERLIPIDEMIC AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-10-30 WO disclosed